360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Schering-Plough Corp

Type: Company

Name: Schering-Plough Corp (Schering Plough Corporation)

Web Address: http://www.schering-plough.se

Fact Sheet: Fact Sheet for Schering Plough Corporation

First reported 4 hours ago - Updated 4 hours ago - 1 reports

Merck pulls plug on Parkinson's drug

has announced the end of the line for its investigational Parkinson's disease drug preladenant, after the drug failed to show much promise in late-stage trials.Analysis of data from three separate Phase III studies did not provide any evidence of efficacy ... [Published Pharma Times - 4 hours ago]

Entities: Drugs, investigational, Schering-Plough Corp, Parkinson's Disease, Placebo

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Sanctuary staff discuss ‘The Big Issue’ with Editor-in-Chief

Staff from Worcester-based housing and care provider Sanctuary Group were given a special insight into the world of The Big Issue this week following an exclusive visit and talk from its founder and Editor-in-Chief John Bird MBE.The presentation, which ... [Published 24dash.com - 14 hours ago]

Entities: Ian McDermott, John Bird, Schering-Plough Corp

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Merck & Co Inc

Bausch + Lomb names new vice president of investor relations

Bausch + Lomb, an eyecare company, has named Alex Kelly as the company's vice president, investor relations, reporting to the company's president and CFO, Bob Bertolini. In this capacity, Kelly will serve as the primary point of contact for the investment ... [Published Individual.com - May 22 2013]

Entities: Investor Relations, Merck & Co Inc, Pharmacia & Upjohn Inc, Schering-Plough Corp

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Sanctuary Group staff take part in volunteering day

Sanctuary Group staff collectively donated around 85 hours to volunteering on national Give and Gain Day on 17 May.Employees from the housing and care provider took part in a variety of projects, including: repainting a community centre on the Kingsmead ... [Published Employee Benefits.co.uk - May 22 2013]

Entities: Schering-Plough Corp, Sheffield, London

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Fred Hassan

The Friendly Persuasion

While it is widely known that the biopharmaceutical industry is confronting disruptive changes to a business model that dates back well into the last century, less is said about the generational shift taking place among managers at every level of today's ... [Published Pharmaceutical Executive - May 22 2013]

Entities: Fred Hassan, Biopharmaceuticals, Business Cycle, embryonic

First reported May 21 2013 - Updated May 21 2013 - 1 reports

infliximab

The Ulcerative Colitis Game Of Thrones

According to this statement from the FDA, about 620,000 Americans suffer from ulcerative colitis, a chronic inflammatory bowel disease. The string of recent FDA approvals of existing rheumatoid arthritis medications for ulcerative colitis has the drug ... [Published Seeking Alpha - May 21 2013]

Entities: Ulcerative Colitis, HUMIRA, SIMPONI, infliximab

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Schering-Plough Corp

Construction Apprenticeship Event

Scarborough Jobmatch are hosting an open day to promote local employment and training opportunities on Friday 24th May 2013 10:00am - 3:00pm at Eastfield Community Centre, High Street, EastfieldSanctuary Group and Keepmoat are working in partnership to ... [Published Yorkshire Coast Radio - May 21 2013]

Entities: Construction, Schering-Plough Corp, Jobcentre Plus

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Merck & Co., Inc. Management Presents at UBS Global Healthcare Conference (Transcript)

Merck & Co., Inc. (MRK) UBS Global Healthcare Conference Call May 20, 2013 10:30 AM ETMarc Goodman - UBSSo good morning everybody, thanks for joining us for the conference. I am Marc Goodman, I cover large cap pharma and specialty pharma for UBS. And ... [Published Seeking Alpha - May 20 2013]

Entities: Merck & Co Inc, Patent, Mergers & Acquisitions, SITAGLIPTIN

First reported May 20 2013 - Updated May 20 2013 - 2 reports

Moody's downgrades UK housing association credit ratings for second time in 2013

Moody's has downgraded the credit ratings of 29 UK housing associations for the second time this year.The ratings agency says its decision to downgrade by one notch was driven by a downward reassessment of the "potential provision of extraordinary su ... [Published 24dash.com - May 20 2013]

Entities: Moody's Corporation, Credit Ratings, United Kingdom, Joseph Carr, Schering-Plough Corp

First reported May 20 2013 - Updated May 20 2013 - 4 reports

Volunteers lend a helping hand to Plymouth drop-in centre

Visitors at the Shekinah drop-in centre in Plymouth were served up a treat on Friday by staff from Sanctuary Group who were volunteering for national Give and Gain Day.The centre, which provides support for adults with multiple and complex needs from ... [Published 24dash.com - May 20 2013]

Entities: Schering-Plough Corp, Business In The Community, United Kingdom

First reported May 19 2013 - Updated May 19 2013 - 1 reports

New scheme to help lower your energy bills

A new scheme to help people save energy - and cash on their bills - has been launched in Hanover Road.The Choices 4 Energy advice shop was opened on Saturday by Scarborough’s mayor, Cllr Helen Mallory.The initiative, which will give people access to free ... [Published NewsRT.co.uk - May 19 2013]

Entities: Schering-Plough Corp, White rose, Hanover

First reported May 15 2013 - Updated May 15 2013 - 3 reports

Apelian is Achillion's first medical chief

Achillion Pharmaceuticals Inc. named David Apelian M.D. to be the New Haven drug-developer's first-ever chief medical officer.Apelian, who will be executive vice president, will oversee clinical development of Achillion's portfolio of compounds to treat ... [Published Hartford Business Journal - May 15 2013]

Entities: Pharmasset Inc, Schering-Plough Corp, GlobeImmune Inc, Achillion Pharmaceuticals Inc

Quotes

"At MSD we like to balance our portfolio of products. We have some of the biologics . . . but also we still consider ourselves a primary care company. So we have products for diabetes, cardiovascular, respiratory disease, and we are also getting into oncology, infectious disease, vaccines."

Finding the right formula for growth [Published Irish Times - 5 hours ago]

"We are delighted that TJ has agreed to work with some of our young residents, many of whom have experienced homelessness, as we believe he can make a real difference and help them make the right choices for the future."

Sanctuary staff discuss ‘The Big Issue’ with Editor-in-Chief [Published 24dash.com - 14 hours ago]

...the progress Bausch + Lomb has made in transforming itself over the last three years, this is an exciting time to join the company," said Kelly. "I look forward to working with the management team to help Bausch + Lomb realize its vision of becoming the best global eye health company."

Bausch + Lomb names new vice president of investor relations [Published Individual.com - May 22 2013]

...talent and leadership, combined with his agricultural knowledge will play a fundamental role in the success of SFP moving forward," says Sanders. "His conscientious work to establish SFP brands, along with his strategic marketing approach is a central component of working towards our goal to increase fertilizer efficiency and the bottom lines of farmers."

SFP Promotes Acklin, Names New Director Of Marketing [Published Agri Marketing - May 22 2013]

More Content

sort by: Date \| Relevance
Merck pulls plug on Parkinson's drug [Published Pharma Times - 4 hours ago]
Finding the right formula for growth [Published Irish Times - 5 hours ago]
Sanctuary staff discuss ‘The Big Issue’ with Ed... [Published 24dash.com - 14 hours ago]
Bausch + Lomb names new vice president of inves... [Published Individual.com - May 22 2013]
SFP Promotes Acklin, Names New Director Of Mark... [Published Agri Marketing - May 22 2013]
Sanctuary Group staff take part in volunteering... [Published Employee Benefits.co.uk - May 22 2013]
The Friendly Persuasion [Published Pharmaceutical Executive - May 22 2013]
Prolor Biotech Buyout: Is The Opko Bear Case No... [Published Seeking Alpha - May 22 2013]
Bioniche dissidents add Macci as director nominee [Published Stockwatch - May 21 2013]
French Autorité de la Concurrence Fines Sanofi ... [Published Skadden - May 21 2013]
New Routes in Drug Delivery [Published Pharmaceutical & Medical Packaging News - May 21 2013]
Forget Yahoo-Tumblr – This $8.5 billion Deal is... [Published InvestorPlace.com - May 21 2013]
Sanctuary Group offers a helping hand on nation... [Published 24dash.com - May 21 2013]
Hurel Corp. Names MacDonald to Board [Published PE Hub News - May 21 2013]
The Ulcerative Colitis Game Of Thrones [Published Seeking Alpha - May 21 2013]
Hurel Corporation Appoints Leading Pharmaceutic... [Published Individual.com - May 21 2013]
Relypsa Names John Orwin as Chief Executive Off... [Published PredictWallStreet - May 21 2013]
Chasing the cure for Parkinson’s disease [Published PMLive - May 21 2013]
Construction Apprenticeship Event [Published Yorkshire Coast Radio - May 21 2013]
Merck & Co., Inc. Management Presents at UBS Gl... [Published Seeking Alpha - May 20 2013]
Moody's downgrades UK housing association credi... [Published 24dash.com - May 20 2013]
Volunteers lend a helping hand to Plymouth drop... [Published 24dash.com - May 20 2013]
Sanctuary staff ‘Give and Gain’ at Worcester Da... [Published 24dash.com - May 20 2013]
Renal Ventures Management Announces New Preside... [Published BioPortfolio - May 20 2013]
Sanctuary staff get green-fingered with Shiregr... [Published 24dash.com - May 20 2013]
Hackney community centre brightened up by volun... [Published 24dash.com - May 20 2013]
Regulatory concerns prompt ratings downgrade [Published InsideHousing - May 20 2013]
New scheme to help lower your energy bills [Published NewsRT.co.uk - May 19 2013]
Russell J. Howard to Join Prima BioMed's Board ... [Published NewsRX - May 17 2013]
Relypsa Announces Appointment of John Orwin as ... [Published PredictWallStreet - May 15 2013]

Blogs

sort by: Date \| Relevance
How Drug Companies Keep Medicine Out of Reach -... [Published PharmaGossip - May 15 2013] http://www.theatlantic.com/health/archive/2013/05/how-drug-companies-keep-medicine-out-of-reach/275853/? Reuters For almost a decade, the United States has been standing in the way of an idea that could lead to cures for some of the world's most devastating ...
Merck's Liptruzet: A Cause For Shame? [Published In the Pipeline - May 09 2013] Vytorin's been discussed several times around here. The combination of Zetia (ezetimibe), the cholesterol absorption inhibitor discovered at Schering-Plough, with Merck's simvastatin looked as if it should be a very effective cholesterol-lowering medication, ...
Top 10 Companies for New Drug Approvals Over Pa... [Published The Big Red Biotech Blog - Apr 16 2013] Fierce Biotech via Mathew Herper's column in Forbes, reports that J&J had the most drug approvals in the 10 year period ending in 2012. This is one measure of R&D pipeline success (personally I'd like to see the amount of revenue generated from these ...
Some Drug Makers Cut Payments, Meals Provided t... [Published PharmaGossip - Apr 11 2013] via foxbusiness.com wo pharmaceutical companies that are among the biggest payers of fees to doctors reduced such spending last year by double-digit percentages, as greater transparency sheds light on the hundreds of millions of dollars the industry ...
NuvaRing Update 2013: More NuvaRing Lawsuits Fi... [Published Drug Injury Watch - Mar 25 2013] March 2013 Rulings By New Jersey Judge Martinotti And NuvaRing MDL Judge Sippel On Expert Witness Testimony Issues All Go In Favor Of Plaintiffs (Posted by Tom Lamb at DrugInjuryWatch.com ) According to the Merck 2012 Annual Report / Form 10-K ...

Press Releases

sort by: Date \| Relevance
Global Packaging Alliance Holds Annual Meeting ... [Published PR.com Press Releases - Apr 17 2013]
Bausch + Lomb ernennt Robert Bertolini zum Präs... [Published PR Newswire - Feb 26 2013]
Bausch + Lomb designa a Robert Bertolini presid... [Published PR Newswire - Feb 26 2013]
Fitch: Merck's Settlement of Vytorin Class Acti... [Published Business Wire Professional Services News - Feb 14 2013]
Institutional Investors Recover $688 Million Fr... [Published Marketwire - Breaking News Releases - Feb 14 2013]